We are live on ! Find out more
NCCM

Nine Chapters Capital Management Portfolio holdings

AUM $45.4M
1-Year Est. Return 14.43%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+14.43%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.2M
AUM Growth
+$15M
Cap. Flow
+$14.4M
Cap. Flow %
19.36%
Top 10 Hldgs %
13.06%
Holding
348
New
176
Increased
42
Reduced
20
Closed
110

Top Buys

Rank Stock Value
1
ANIK icon
Anika Therapeutics
ANIK
+$1.21M
2
PBI icon
Pitney Bowes
PBI
+$1.09M
3
SNPS icon
Synopsys
SNPS
+$1.04M
4
LMNX
Luminex Corp
LMNX
+$1.03M
5
AGCO icon
AGCO
AGCO
+$948K

Top Sells

Rank Stock Value
1
XRX icon
Xerox
XRX
+$1.2M
2
PPL
PPL Corp
PPL
+$1.09M
3
DF
Dean Foods Company
DF
+$1.09M
4
FE icon
FirstEnergy
FE
+$1.09M
5
GILD icon
Gilead Sciences
GILD
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 20%
2 Healthcare 16.95%
3 Technology 13.59%
4 Consumer Discretionary 11.18%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYNA icon
51
Synaptics
SYNA
$4.19B
$446K 0.6%
+9,000
New +$483K
SCMP
52
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$446K 0.6%
40,500
+28,700
+243% +$333K
AGTC
53
DELISTED
Applied Genetic Technologies Corporation
AGTC
$440K 0.59%
+63,700
New +$498K
SRDX
54
DELISTED
Surmodics
SRDX
$438K 0.59%
+18,200
New +$446K
ESND
55
DELISTED
Essendant Inc.
ESND
$436K 0.59%
28,800
+10,200
+55% +$190K
SNEX icon
56
StoneX
SNEX
$9.26B
$433K 0.58%
+57,713
New +$428K
GRMN
57
Garmin
GRMN
$56.7B
$424K 0.57%
+8,300
New +$418K
TVPT
58
DELISTED
Travelport Worldwide Limited
TVPT
$424K 0.57%
36,000
+26,000
+260% +$346K
ENZ
59
DELISTED
Enzo Biochem, Inc.
ENZ
$422K 0.57%
50,400
+19,500
+63% +$137K
CHFN
60
DELISTED
Charter Financial Corp
CHFN
$421K 0.57%
+21,400
New +$386K
ENS icon
61
EnerSys
ENS
$6.78B
$418K 0.56%
+5,300
New +$413K
PDLI
62
DELISTED
PDL BioPharma, Inc.
PDLI
$415K 0.56%
183,000
+63,300
+53% +$140K
AA icon
63
Alcoa
AA
$11.9B
$409K 0.55%
11,900
-8,600
-42% -$301K
JD icon
64
JD.com
JD
$44.6B
$404K 0.54%
+13,000
New +$383K
QUAD icon
65
Quad
QUAD
$536M
$404K 0.54%
+16,000
New +$410K
NYRT
66
DELISTED
New York REIT, Inc.
NYRT
$400K 0.54%
+4,130
New +$406K
SCLN
67
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$399K 0.54%
+40,700
New +$406K
HY icon
68
Hyster-Yale Materials Handling
HY
$599M
$395K 0.53%
+7,000
New +$424K
AR icon
69
Antero Resources
AR
$11.1B
$381K 0.51%
+16,700
New +$409K
DCO icon
70
Ducommun
DCO
$2.7B
$380K 0.51%
+13,200
New +$385K
VMW
71
DELISTED
VMware, Inc
VMW
$378K 0.51%
4,100
-9,700
-70% -$854K
ZEUS
72
DELISTED
Olympic Steel
ZEUS
$377K 0.51%
+20,300
New +$461K
SHLM
73
DELISTED
Schulman (A.) Inc
SHLM
$368K 0.5%
+11,700
New +$388K
KFRC icon
74
Kforce
KFRC
$1.02B
$363K 0.49%
+15,300
New +$365K
BKU icon
75
Bankunited
BKU
$3.37B
$358K 0.48%
+9,600
New +$365K
1 2
3
4 5

Similar funds

CZPM
Capital Z Partners Management New York $47.4M AUM 35.48% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
DAC
Dymon Asia Capital Singapore $48.4M AUM 73.84% 1-Year Est. Return
TCM
Trishield Capital Management New York $40.3M AUM
SAC
SPQ Asia Capital Hong Kong $37.7M AUM 121.14% 1-Year Est. Return
PCP
Proprium Capital Partners Stamford, Connecticut $54M AUM 7.85% 1-Year Est. Return
TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
A
Aetna Hartford, Connecticut $35.3M AUM 7.55% 1-Year Est. Return

Nine Chapters Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Nine Chapters Capital Management held 348 positions worth $74.2M, up 25% from $59.1M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Nine Chapters Capital Management deployed $14.4M of net new capital in Q1 2017, opening 176 new positions and adding to 42 existing holdings. Its largest new stake was Anika Therapeutics: 25,300 shares worth $1.1M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Xerox, an estimated $1.2M trimmed.

  • Nine Chapters Capital Management's largest Q1 2017 buy was Anika Therapeutics: 25,300 shares worth $1.1M.
  • Nine Chapters Capital Management added most to RR Donnelley & Sons Co. in Q1 2017, an estimated $648K increase.
  • Nine Chapters Capital Management's biggest Q1 2017 reduction was Xerox, cutting an estimated $1.2M.
  • Nine Chapters Capital Management fully exited PPL Corp in Q1 2017, selling an estimated $1.09M.
  • Nine Chapters Capital Management's ten largest holdings make up 13% of its $74.2M portfolio in Q1 2017.
  • Nine Chapters Capital Management opened 176 new positions and closed 110 in Q1 2017.
  • Nine Chapters Capital Management's portfolio value rose 25% quarter-over-quarter to $74.2M.

Based on Nine Chapters Capital Management's 13F filing for Q1 2017, filed 8 May 2017.